Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 21

1.

ATXN2 polyQ intermediate repeats are a modifier of ALS survival.

Chiò A, Calvo A, Moglia C, Canosa A, Brunetti M, Barberis M, Restagno G, Conte A, Bisogni G, Marangi G, Moncada A, Lattante S, Zollino M, Sabatelli M, Bagarotti A, Corrado L, Mora G, Bersano E, Mazzini L, D'Alfonso S; PARALS.

Neurology. 2015 Jan 20;84(3):251-8. doi: 10.1212/WNL.0000000000001159. Epub 2014 Dec 19.

PMID:
25527265
2.

Thrombophilic disorders in migraine.

Cavestro C, Mandrino S.

Front Neurol. 2014 Jul 10;5:120. doi: 10.3389/fneur.2014.00120. eCollection 2014. Review. No abstract available.

3.

Amyotrophic lateral sclerosis outcome measures and the role of albumin and creatinine: a population-based study.

Chiò A, Calvo A, Bovio G, Canosa A, Bertuzzo D, Galmozzi F, Cugnasco P, Clerico M, De Mercanti S, Bersano E, Cammarosano S, Ilardi A, Manera U, Moglia C, Sideri R, Marinou K, Bottacchi E, Pisano F, Cantello R, Mazzini L, Mora G; Piemonte and Valle d’Aosta Register for Amyotrophic Lateral Sclerosis.

JAMA Neurol. 2014 Sep;71(9):1134-42. doi: 10.1001/jamaneurol.2014.1129.

PMID:
25048026
4.

Headache prevalence and related symptoms, family history, and treatment habits in a representative population of children in Alba, Italy.

Cavestro C, Montrucchio F, Benci P, Pompilio D, Mandrino S, Cencio PG, Frigeri MC, Di Pietrantonj C.

Pediatr Neurol. 2014 Sep;51(3):348-53. doi: 10.1016/j.pediatrneurol.2014.05.022. Epub 2014 May 29.

PMID:
24993247
5.

Non-invasive ventilation in amyotrophic lateral sclerosis: a 10 year population based study.

Chiò A, Calvo A, Moglia C, Gamna F, Mattei A, Mazzini L, Mora G; PARALS.

J Neurol Neurosurg Psychiatry. 2012 Apr;83(4):377-81. doi: 10.1136/jnnp-2011-300472. Epub 2011 Oct 19.

PMID:
22013242
6.

ALS clinical trials: do enrolled patients accurately represent the ALS population?

Chiò A, Canosa A, Gallo S, Cammarosano S, Moglia C, Fuda G, Calvo A, Mora G; PARALS group.

Neurology. 2011 Oct 11;77(15):1432-7. doi: 10.1212/WNL.0b013e318232ab9b. Epub 2011 Sep 28.

PMID:
21956723
7.

Migraineurs show a high prevalence of antiphospholipid antibodies.

Cavestro C, Micca G, Molinari F, Bazzan M, DI Pietrantonj C, Aloi R, Pedemonte E, Iannini R, Frigeri MC, Roccatello D.

J Thromb Haemost. 2011 Jul;9(7):1350-4. doi: 10.1111/j.1538-7836.2011.04348.x.

PMID:
21585648
8.

Treatment of first tonic-clonic seizure does not affect mortality: long-term follow-up of a randomised clinical trial.

Leone MA, Vallalta R, Solari A, Beghi E; FIRST Group.

J Neurol Neurosurg Psychiatry. 2011 Aug;82(8):924-7. doi: 10.1136/jnnp.2010.240069. Epub 2011 Apr 28.

PMID:
21531706
9.

Anatomical variants of the circle of willis and brain lesions in migraineurs.

Cavestro C, Richetta L, L'episcopo MR, Pedemonte E, Duca S, Di Pietrantonj C.

Can J Neurol Sci. 2011 May;38(3):494-9.

PMID:
21515511
10.

Phenotypic heterogeneity of amyotrophic lateral sclerosis: a population based study.

Chiò A, Calvo A, Moglia C, Mazzini L, Mora G; PARALS study group.

J Neurol Neurosurg Psychiatry. 2011 Jul;82(7):740-6. doi: 10.1136/jnnp.2010.235952. Epub 2011 Mar 14.

PMID:
21402743
11.

The epidemiology and treatment of ALS: focus on the heterogeneity of the disease and critical appraisal of therapeutic trials.

Beghi E, Chiò A, Couratier P, Esteban J, Hardiman O, Logroscino G, Millul A, Mitchell D, Preux PM, Pupillo E, Stevic Z, Swingler R, Traynor BJ, Van den Berg LH, Veldink JH, Zoccolella S; Eurals Consortium.

Amyotroph Lateral Scler. 2011 Jan;12(1):1-10. doi: 10.3109/17482968.2010.502940. Epub 2010 Aug 11. Review.

12.

Tracheostomy in amyotrophic lateral sclerosis: a 10-year population-based study in Italy.

Chiò A, Calvo A, Ghiglione P, Mazzini L, Mutani R, Mora G; PARALS.

J Neurol Neurosurg Psychiatry. 2010 Oct;81(10):1141-3. doi: 10.1136/jnnp.2009.175984. Epub 2010 Jul 26.

PMID:
20660920
13.

Sneddon's syndrome presenting with severe disabling bilateral headache.

Cavestro C, Richetta L, Pedemonte E, Asteggiano G.

J Headache Pain. 2009 Jun;10(3):211-3. doi: 10.1007/s10194-009-0109-3. Epub 2009 Mar 14.

14.

Epidemiology of ALS in Italy: a 10-year prospective population-based study.

Chiò A, Mora G, Calvo A, Mazzini L, Bottacchi E, Mutani R; PARALS.

Neurology. 2009 Feb 24;72(8):725-31. doi: 10.1212/01.wnl.0000343008.26874.d1.

PMID:
19237701
15.

Insulin metabolism is altered in migraineurs: a new pathogenic mechanism for migraine?

Cavestro C, Rosatello A, Micca G, Ravotto M, Marino MP, Asteggiano G, Beghi E.

Headache. 2007 Nov-Dec;47(10):1436-42.

PMID:
18052953
16.

High prolactin levels as a worsening factor for migraine.

Cavestro C, Rosatello A, Marino MP, Micca G, Asteggiano G.

J Headache Pain. 2006 Apr;7(2):83-9. Epub 2006 Mar 15.

17.

Chronic alcohol use and first symptomatic epileptic seizures.

Leone M, Tonini C, Bogliun G, Monaco F, Mutani R, Bottacchi E, Gambaro P, Rocci E, Tassinari T, Cavestro C, Beghi E.

J Neurol Neurosurg Psychiatry. 2002 Nov;73(5):495-9.

18.

Incidence, risk factors and short-term mortality of stroke in Vittoria, southern Italy.

Iemolo F, Beghi E, Cavestro C, Micheli A, Giordano A, Caggia E.

Neurol Sci. 2002 Apr;23(1):15-21.

PMID:
12111616
19.

Incidence of ALS in Italy: evidence for a uniform frequency in Western countries.

Piemonte and Valle d'Aosta Register for Amyotrophic Lateral Sclerosis (PARALS).

Neurology. 2001 Jan 23;56(2):239-44.

PMID:
11160962
20.

Evidence for a subclinical involvement of the central nervous system in mild or moderate chronic respiratory insufficiency.

Barbieri S, Fayoumi Z, Berardinelli P, Cappellari A, Cavestro C, Valli G, Scarlato G.

Electromyogr Clin Neurophysiol. 1996 Mar;36(2):67-72.

PMID:
8925782
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk